Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 22, 2012

View Archived Issues

Eisai describes new clinical candidate for anxiety and depression

Novel nanotechnology targets t-PA to obstructed blood vessels

Novel DAAO inhibitor shows potential to treat schizophrenia

Small molecule shows potential for as a contraceptive for men

New DNA tests developed for hereditary diseases

Medivir moves MIV-711 into phase Ib testing

Orexo plans NDA for sublingual buprenorphine/naloxone product

Pluristem and BCRT renew 5-year collaboration

New phase III data disclosed on Inavir

Novel prosthetic incorporates retinal code to restore vision

NIH awards HIV vaccine research grants

Aurum Biosciences and Oxygen Biotherapeutics present novel Oxycyte data

Scientists at Novartis synthesize novel CDK9 inhibitors

Investigation at Sphaera Pharma yields new PI3K/mTOR inhibitors

Boehringer Ingelheim Pharma reports new SYK inhibitors

New pim-1/2 inhibitors developed

Novel tyrosine kinase inhibitors patented by Pierre Fabre Medicament

Glymera enters phase IIb trial for uncontrolled type 2 diabetes

FDA extends tofacitinib NDA PDUFA date

FDA to discuss Gattex NDA at advisory committee meeting

Vernalis kicks off receptor occupancy study of V-81444

Foundation Fighting Blindness to fund eight projects for retinal degenerative diseases

NICE issues new guidance on bevacizumab

VolitionRX and Belgian hospital sign agreement for prospective colon cancer trial

Research collaboration begins for delivery of microRNA-based therapeutics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...